Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Helsinki
Headquarters: Helsinki, Finland
Website: http://www.helsinki.fi/univ...
Year Founded: 1640
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Mar 5, 2024
Discovery & Translation
Distillery spotlight: new Alzheimer’s mechanisms from academia
BioCentury’s survey of the 2023 translational literature highlights a cluster of neuron-targeting mechanisms for Alzheimer’s disease
BioCentury | Apr 6, 2023
Discovery & Translation
Targeted DNA integration; plus Janssen’s small molecule dengue inhibitor and more
BioCentury’s roundup of translational news
BioCentury | Apr 8, 2021
Product Development
Rounding up intranasal COVID-19 vaccines: Data Byte
In the race to develop the next generation of COVID-19 vaccines, at least 22 vaccine programs are being developed with an intranasal route of administration. Intranasal vaccines may provide
BioCentury | Dec 31, 2020
Distillery Therapeutics
SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Mitochondrial disease Promoting the expression of the desuccinylase SIRT5 could treat a hereditary mitochondrial encephalomyopathy caused by
INDICATION: Mitochondrial disease Promoting the expression of the desuccinylase SIRT5 could treat a hereditary mitochondrial encephalomyopathy caused by
BioCentury | Nov 6, 2020
Targets & Mechanisms
Data Byte: newly identified host factors that regulate ACE2 expression
Several recent publications highlighting host factors that modulate ACE2 expression point to possible new targets for COVID-19 therapies. ACE2 and TMPRSS2 are the most common host targets
BioCentury | Jun 18, 2020
Finance
June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX
BioCentury | Feb 14, 2020
Targets & Mechanisms
Entrepreneur watch: Iwasaki targets the lymphatic system to clear brain tumors
After starting two companies this year, Yale’s Akiko Iwasaki clears glioblastoma in mice via brain lymphatics
BioCentury | Dec 6, 2019
Targets & Mechanisms
Emerging immuno-oncology mechanisms at ASH 2019
Immune system biomarkers take center stage among emerging targets at ASH 2019
Items per page:
1 - 10 of 53